Merck Sells DoD Financed Covid Pill Molnupiravir At 40 Times The Cost Price

According to a report, the US Department of Defense financed COVID pill Molnupiravir is being sold by Merck at 40 times the actual cost price.

Merck Sells DoD Financed Covid Pill Molnupiravir At 40 Times The Cost Price

A 5 day course of molnupiravir, costs $17.74 to produce, according to a report (read below) published by The Intercept issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London.

However, Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

A small Miami-based company, Ridgeback licensed the medicine from Emory University in 2020 and two months later sold the worldwide rights to the drug to Merck for an undisclosed sum.

Although Ridgeback remains involved in the development of the drug, some have described the deal as “flipping.”

Subscribe to GreatGameIndia

Enter your email address to subscribe to GGI and receive notifications of new posts by email.

The pill could bring staggering profits to both Merck and Ridgeback Biotherapeutics. 

The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, also provided Emory with more than $19 million in additional grants.

Yet only Merck and Ridgeback will reap the profits from the new antiviral, which according to Quartz could bring in as much as $7 billion by the end of this year.

In June, the government signed a $1.2 billion contract with Merck to supply 1.7 million courses of the medication at the $712 price.

The transaction is due to take place as soon as molnupiravir receives emergency use authorization from the Food and Drug Administration.

A whistleblower complaint filed by Rick Bright, the former director of the Biomedical Advanced Research and Development Authority, or BARDA, in May 2020, described Ridgeback’s unsuccessful efforts “to secure approximately $100 million” from BARDA to develop the drug as a Covid-19 treatment.

Molnupiravir was developed for the treatment of Influenza. According to whistleblower complaint Molnupiravir has mutagenic properties and may change your DNA.

Now, Molnupiravir has been repurposed for COVID-19. Merck has entered into agreements with Indian manufacturers and has also announced $5 million of donations to enter into Indian market. Here is all you need to know about Merck’s Covid pill Molnupiravir.

Read the report below:

Merck-Sells-DoD-Financed-Covid-Pill-Molnupiravir-At-40-Times-The-Cost-Price

We need your support to carry on our independent and investigative research based journalism on the Deep State threats facing humanity. Your contribution however small helps us keep afloat. Kindly consider supporting GreatGameIndia.

Support GreatGameIndia

8 COMMENTS

  1. Well the USA has to do SOMETHING with all that extra cash right? Since we have no homelessness, no deteriorating infrastructure, our schools and hospitals are all in good shape and free to anyone who needs them……oh wait….none of that is true!!!! So why are we pouring money down the drain with ridiculous things like spending 40x the cost price for a totally ineffective substance which does not even qualify to be called a medicine? If anything it should be called a toxin as this substance causes irreparable harm to DNA. What the heck are we thinking?!? WE are not thinking! WE are not allowed to do so. WE just follow along like drugged sheep. It is high time to WE wake up! Of course for that to happen, we would have to get off of the mind-numbing toxins that are put in our water supply.
    Thank you GGI for bringing this matter, and many others, to light. If enough people are made aware of what is really going on, there will be hope for the future of humanity.

  2. Real Online home based work to make more than $14k. Last month i have made $15738 from this home job. Very simple and easy to do and earnings from this a re just awesome for dertails. For more details. For more detail visit the given link……… http://moneybank1.tk

  3. This is NOT Ivermectin, it is a DNA changing carcinogen… They hope to sell it as a “super Ivermectin”…. how evil these pharmacy
    companies are!

Leave a Reply